23 Recruiting Lymphoma, B-Cell Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceTop Recruiting Lymphoma, B-Cell Studies
Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
📍 Memorial Sloan Kettering Cancer Center (All protocol activities) — New York, New York
View Study & Checklist ➔A Study of Nemtabrutinib (MK-1026) in Participants With Relapsed or Refractory Hematologic Malignancies (ARQ 531-101/MK-1026-001)
📍 Mayo Clinic Hospital ( Site 0140) — Scottsdale, Arizona
View Study & Checklist ➔FT819 in Subjects With B-cell Malignancies
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
📍 City of Hope — Duarte, California
View Study & Checklist ➔A Phase 1/2 Study of STP938 (Dencatistat) for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas
📍 Colorado Blood Cancer Institute — Denver, Colorado
View Study & Checklist ➔Phase I Master Protocol of Novel Combination Therapy for Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma
📍 BCCA - Vancouver — Vancouver, British Columbia
View Study & Checklist ➔Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.
📍 Providence Health System - Southern California d/b/a Roy and Patricia Disney Family Cancer Center, The Roy & Patricia Disney Family Cancer Center — Burbank, California
View Study & Checklist ➔Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma
📍 Local Institution - 162 — Birmingham, Alabama
View Study & Checklist ➔Phase 1 Trial of BTM-3566 in Relapsed/Refractory Mature B Cell Lymphomas
📍 Levine Cancer Institute, Atrium Health — Charlotte, North Carolina
View Study & Checklist ➔